Inventor · disambiguated record
Ken Ishii
Also filed as: ISHII KEN · ISHII KEN J
26 granted patents·16 pending applications·295 citations·filing 2002–2023
95Inventor score
Files withNAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION9US HEALTH7UNIV OSAKA4DAIICHI SANKYO CO LTD3KLINMAN DENNIS3
Top patents by PatentIndex Score
42 records- 0196US8030285B2Oligodeoxynucleotide and its use to induce an immune responseUS HEALTH·Filed 2006·Granted Oct 4, 2011·36 cites·32 claims
- 0296US7960356B2Oligodeoxynucleotide and its use to induce an immune responseUS HEALTH·Filed 2005·Granted Jun 14, 2011·24 cites·42 claims
- 0395US6977245B2Oligodeoxynucleotide and its use to induce an immune responseUS HEALTH·Filed 2002·Granted Dec 20, 2005·67 cites·13 claims
- 0494US7919477B2Multiple CpG oligodeoxynucleotides and their use to induce an immune responseUS HEALTH·Filed 2007·Granted Apr 5, 2011·24 cites·36 claims
- 0593US7521063B2Multiple CPG oligodeoxynucleotides and their use to induce an immune responseUS HEALTH·Filed 2002·Granted Apr 21, 2009·47 cites·14 claims
- 0692US8232259B2Multiple CpG oligodeoxynucleotide and their use to induce an immune responseKLINMAN DENNIS·Filed 2011·Granted Jul 31, 2012·20 cites·19 claims
- 0792US7666674B2Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivoUS HEALTH·Filed 2002·Granted Feb 23, 2010·48 cites·25 claims
- 0891US8227446B2Oligodeoxynucleotide and its use to induce an immune responseKLINMAN DENNIS·Filed 2011·Granted Jul 24, 2012·8 cites·27 claims
- 0983US11058758B2TH1-inducing adjuvant comprising combination of different nucleic acid adjuvants, and use of sameNAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION·Filed 2015·Granted Jul 13, 2021·4 cites·8 claims
- 1080US10202606B2Complex containing oligonucleotide having immunopotentiating activity and use thereofNAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION·Filed 2014·Granted Feb 12, 2019·6 cites·28 claims
- 1177US11015202B2Complex containing oligonucleotide having immunopotentiating activity and use thereofNAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION·Filed 2018·Granted May 25, 2021·1 cites·9 claims
- 1276US8389495B2Olioodeoxynucleotide and its use to induce an immune responseKLINMAN DENNIS·Filed 2011·Granted Mar 5, 2013·2 cites·23 claims
- 1374US12319727B2Exosome-targeted DNA vaccineEXORPHIA INC·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 1474US8846867B2Isolation of anti-desmoglein 1 antibodies by phage display of pemphigus foliaceus autoantibodiesPAYNE AIMEE S·Filed 2008·Granted Sep 30, 2014·5 cites·17 claims
- 1569US12414988B2Th1-inducing adjuvant comprising combination of different nucleic acid adjuvants and use of sameISHII KEN·Filed 2023·Granted Sep 16, 2025·0 cites·6 claims
- 1669US2010104507A1Use of sterically stabilized cationic liposomes to efficiently deliver cpg oligonucleotides in vivoUS GOV HEALTH & HUMAN SERV·Filed 2009·Application pending·0 cites
- 1768US8894996B2Immunoadjuvant composition and use thereofAKIRA SHIZUO·Filed 2010·Granted Nov 25, 2014·3 cites·3 claims
- 1866US9028843B2Malaria vaccineUNIV OSAKA·Filed 2014·Granted May 12, 2015·0 cites·4 claims
- 1965US12209115B2Exosome-targeted DNA vaccineEXORPHIA INC·Filed 2022·Granted Jan 28, 2025·0 cites·11 claims
- 2065US2025250567A1Protozoa transcription factor inhibitorUNIV TOKYO·Filed 2023·Application pending·0 cites
- 2164US2025268931A1Transcriptional inhibitor for immune-related geneUNIV TOKYO·Filed 2023·Application pending·0 cites
- 2262US2025222108A1Medical agent including adjuvant and composite of photosensitive molecule and molecule binding to cancer-specific cell surface moleculeUNIV KYOTO·Filed 2022·Application pending·0 cites
- 2361US8741869B2Oligodeoxynucleotide and its use to induce an immune responseUS HEALTH·Filed 2013·Granted Jun 3, 2014·0 cites·23 claims
- 2461US2021299239A1Novel th1-inducing adjuvant comprising combination of different nucleic acid adjuvants, and use of sameNAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION·Filed 2021·Application pending·0 cites
- 2554US10172927B2Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity inductionUNIV OSAKA·Filed 2016·Granted Jan 8, 2019·0 cites·3 claims
- 2654US2025381264A2Htlv-1 nucleic acid lipid particle vaccineNAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION·Filed 2022·Application pending·0 cites
- 2753US9056094B2AdjuvantTSUKUI TOSHIHIRO·Filed 2008·Granted Jun 16, 2015·0 cites·7 claims
- 2853US2024000954A1Complex of beta-glucan and nucleic acid having controlled particle sizeDAIICHI SANKYO CO LTD·Filed 2021·Application pending·0 cites
- 2952US9400279B2Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity inductionAKIRA SHIZUO·Filed 2011·Granted Jul 26, 2016·0 cites·1 claims
- 3052US2023248819A1Nucleic acid lipid particle vaccineDAIICHI SANKYO CO LTD·Filed 2021·Application pending·0 cites
- 3152US2009041808A1Detection/Measurement Of Malaria Infection Disease Utilizing Natural Immunity By Hemozoin Induction, Screening Of Preventative Or Therapeutic Medicine For Malaria Infection Disease, And Regulation Of Natural Immunity InductionUNIV OSAKA·Filed 2005·Application pending·0 cites
- 3251US2019112351A1Exosome-targeted dna vaccineNAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION·Filed 2016·Application pending·0 cites
- 3350US2018256630A1Use of nucleic acid-polysaccharide complexes having immunopotentiating activity as anti-tumor drugNAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION·Filed 2014·Application pending·0 cites
- 3448US2024159741A1New treatment and prevention based on new method for controlling cellular immunityISHII KEN·Filed 2022·Application pending·0 cites
- 3547US8808712B2Malaria vaccineHORII TOSHIHIRO·Filed 2010·Granted Aug 19, 2014·0 cites·5 claims
- 3647US2022409540A1Nucleic acid lipid particle vaccine encapsulating hpv mrnaDAIICHI SANKYO CO LTD·Filed 2020·Application pending·0 cites
- 3746US9732107B2Method for producing beta-hematin crystal comprising step of heatingUNIV OSAKA·Filed 2014·Granted Aug 15, 2017·0 cites·5 claims
- 3845US2022401545A1Novel treatment and prevention of disease based on immunological memoryNAT INSTITUTE OF BIOMEDICAL INNOVATION HEALTH AND NUTRITION·Filed 2020·Application pending·0 cites
- 3944US12306171B2Method for detecting indicator of immune-related diseaseMANDOM CORP·Filed 2019·Granted May 20, 2025·0 cites·9 claims
- 4040US11268098B2Non-aggregating immunostimulatory oligonucleotidesNAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION·Filed 2015·Granted Mar 8, 2022·0 cites·13 claims
- 4139US2018353598A1Optimization of physiological properties of calcium phosphate as vaccine adjuvantNAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION·Filed 2016·Application pending·0 cites
- 4238US2013034731A1ADJUVANT CONTAINING beta-HEMATINNIPPON ZENYAKU KOGYO CO LTD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ken Ishii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →